Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search

Secondary prevention

Citations 241-250 of 568 total displayed.

Past content (since Feb 1999):

Articles
Clinical Progression of Incidental, Asymptomatic Lesions Discovered During Culprit Vessel Coronary Intervention
Ruchira Glaser, Faith Selzer, David P. Faxon, Warren K. Laskey, Howard A. Cohen, James Slater, Katherine M. Detre, and Robert L. Wilensky
Circulation published December 27, 2004, doi:10.1161/01.CIR.0000150335.01285.12 [Abstract]  

AHA Conference Proceedings
CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: Report From the Clinical Practice Discussion Group
Sidney C. Smith, Jr, Jeffrey L. Anderson, Richard O. Cannon, III, Yazid Y. Fadl, Wolfgang Koenig, Peter Libby, Steven E. Lipshultz, George A. Mensah, Paul M Ridker, and Robert Rosenson
Circulation 2004;110:e550-553e, doi:10.1161/01.CIR.0000148981.71644.C7 [Full text]  

AHA Conference Proceedings
CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: Clinical Use of Inflammatory Markers in Patients With Cardiovascular Diseases: A Background Paper
Luigi M. Biasucci
Circulation 2004;110:e560-567e, doi:10.1161/01.CIR.0000148983.88334.80 [Abstract] [Full text]  

Editorials
Atherosclerosis Imaging and the Future of Lipid Management
Scott M. Grundy
Circulation 2004;110:3509-3511, doi:10.1161/01.CIR.0000151100.28000.B3 [Full text]  

Vascular Medicine
Effects of the Acyl Coenzyme A:Cholesterol Acyltransferase Inhibitor Avasimibe on Human Atherosclerotic Lesions
Jean-Claude Tardif, Jean Grégoire, Philippe L. L’Allier, Todd J. Anderson, Olivier Bertrand, Francois Reeves, Lawrence M. Title, Fernando Alfonso, Erick Schampaert, Alita Hassan, Richard McLain, Milton L. Pressler, Reda Ibrahim, Jacques Lespérance, John Blue, Therese Heinonen, Josep Rodés-Cabau for the Avasimibe and Progression of Lesions on UltraSound (A-PLUS) Investigators
Circulation 2004;110:3372-3377; published online before print as doi:10.1161/01.CIR.0000147777.12010.EF [Abstract] [Full text]  

New Drugs and Technologies
Which Inhibitor of the Renin–Angiotensin System Should Be Used in Chronic Heart Failure and Acute Myocardial Infarction?
John J.V. McMurray, Marc A. Pfeffer, Karl Swedberg, and Victor J. Dzau
Circulation 2004;110:3281-3288, doi:10.1161/01.CIR.0000147274.83071.68 [Full text]  

Articles
Effects of the Acyl Coenzyme A:Cholesterol Acyltransferase Inhibitor Avasimibe on Human Atherosclerotic Lesions
Jean-Claude Tardif, Jean Grégoire, Philippe L. L’Allier, Todd J. Anderson, Olivier Bertrand, Francois Reeves, Lawrence M. Title, Fernando Alfonso, Erick Schampaert, Alita Hassan, Richard McLain, Milton L. Pressler, Reda Ibrahim, Jacques Lespérance, John Blue, Therese Heinonen, Josep Rodés-Cabau for the Avasimibe and Progression of Lesions on UltraSound (A-PLUS) Investigators
Circulation published November 8, 2004, doi:10.1161/01.CIR.0000147777.12010.EF [Abstract]  

Coronary Heart Disease
Ascorbic Acid Prevents Contrast-Mediated Nephropathy in Patients With Renal Dysfunction Undergoing Coronary Angiography or Intervention
Konstantinos Spargias, Elias Alexopoulos, Stamatis Kyrzopoulos, Panayiotis Iacovis, Darren C. Greenwood, Athanassios Manginas, Vassilis Voudris, Gregory Pavlides, Christopher E. Buller, Dimitrios Kremastinos, and Dennis V. Cokkinos
Circulation 2004;110:2837-2842; published online before print as doi:10.1161/01.CIR.0000146396.19081.73 [Abstract] [Full text]  

Vascular Medicine
Anti–Glycoprotein VI Treatment Severely Compromises Hemostasis in Mice With Reduced {alpha}2ß1 Levels or Concomitant Aspirin Therapy
Sabine Grüner, Miroslava Prostredna, Barsom Aktas, Alexandra Moers, Valerie Schulte, Thomas Krieg, Stefan Offermanns, Beate Eckes, and Bernhard Nieswandt
Circulation 2004;110:2946-2951; published online before print as doi:10.1161/01.CIR.0000146341.63677.3C [Abstract] [Full text]  

Articles
Anti-Glycoprotein VI Treatment Severely Compromises Hemostasis in Mice With Reduced {alpha}2{beta}1 Levels or Concomitant Aspirin Therapy
Sabine Grüner, Miroslava Prostredna, Barsom Aktas, Alexandra Moers, Valerie Schulte, Thomas Krieg, Stefan Offermanns, Beate Eckes, and Bernhard Nieswandt
Circulation published October 25, 2004, doi:10.1161/01.CIR.0000146341.63677.3C [Abstract]  

[First page]   [Previous page]   [Next page]
Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57

* Subspecialty Collections Home

* Show  Secondary prevention
 collections from other journals.

* Related collections:
 Treatment
 Ablation/ICD/surgery
 Behavioral/psychosocial - treatment
 Cardiovascular Pharmacology
 Catheter-based coronary and valvular interventions: other
 Catheter-based coronary interventions: stents
 Compliance/Adherence
 CPR and emergency cardiac care
 Exercise/exercise testing/rehabilitation
 Pacemaker
 Primary prevention
 Restenosis
 Secondary prevention
 Other Treatment